Early Versus Delayed Pneumococcal Vaccination in HIV

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

October 31, 2007

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Pneumovax

BIOLOGICAL

Prevnar

Trial Locations (14)

V1Y 1T2

Medical Arts Health Research Group, Kelowna

Unknown

Downtown IDC, Vancouver

St. Paul's Hospital, Vancouver

St. Boniface General Hospital, Winnipeg

Moncton Hospital, Windsor

Victoria General, Halifax

McMaster University, Hamilton

St. Joseph's Hospital, London

Sunnybrook, Toronto

Toronto General, Toronto

Metropolitan Hospital, Windsor

Montreal Chest/Royal-Victoria, Montreal

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

Centre Hospitalier Universitaire de Laval, Ste-Foy

All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

CIHR Canadian HIV Trials Network

NETWORK

NCT00137605 - Early Versus Delayed Pneumococcal Vaccination in HIV | Biotech Hunter | Biotech Hunter